Viewing Study NCT05206357

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2026-01-03 @ 7:59 PM
Study NCT ID: NCT05206357
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-08
First Post: 2022-01-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab
Sponsor: Genmab
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-hodgkin Lymphoma View
None ABBV-GMAB-3013 View
None Epcoritamab View
None Burkitt's or Burkitt-like Lymphoma/Leukemia View
None Diffuse Large B-cell Lymphoma View
None Aggressive Mature (CD20+) B-cell Lymphoma View
None Cancer View
None Relapsed/Refractory Aggressive Mature B-cell Neoplasms View
None EPCORE View